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ABSTRACT
It is now well established that genetic background influences an athlete’s 
ability to excel in different sport disciplines. Previous studies have dem-
onstrated that among power athletes, single nucleotide polymorphism 
(SNP) in the AGT genotype (Thr-Thr), was significantly more preva-
lent among weightlifters compared to sprinters and jumpers indicating 
that despite the common features of these sport subtypes (short and very 
intense), they vary in their strength and speed abilities, as well as in their 
genetic make-up. The aim of the present study was to assess whether 
the AGT SNP can be used also to distinguish elite from national levels 
weightlifters. The AGT M235T genotype frequencies were assessed in 47 
weightlifters (30 elite, 17 national level) and 86 non-athletes control. The 
Thr-Thr  genotype was significantly higher among weightlifters (29.8%) 
compared to controls (12.8%) (p=0.048). Thr allele frequency was signi-
ficantly higher among weightlifters (55.3%) compared to controls (37.8%) 
(p=0.021). However, there was no difference in the prevalence of the poly-
morphism between national level and elite athletes. In conclusion, the 
results suggest that the AGT polymorphism cannot predict elite competi-
tive weightlifting performance. 
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INTRODUCTION
Anaerobic-type sport events are characterized by high intensity activities 
lasting few seconds using different proportions of power, speed and strength. 
Weightlifting is considered one of the more explosive-type anaerobic events 
characterized by maximal force production and slow velocity lifts. The ini-
tiation of the lifting movement is explosive, but the subsequent movement 
is at a rather slow velocity due to the high load and the associated lifting 
biomechanics [3, 9, 16]. However, during training weightlifters use both 
standard resistance exercise techniques, including heavy load, slow velocity 
movements as well as explosive type lifts such as snatch, clean and jerk [12]. 
This allows for the use of heavy loads and high velocities simultaneously, 
thus producing higher power outputs [9, 10] and increasing concurrently 
muscle strength and power [13].
It is now well known that genetic background influences an athlete’s capa-
bility to excel in different sport disciplines like weightlifting. Genetics have a 
large influence on muscle cross-sectional area and size, muscle fibre type (fast 
versus slow twitch) and muscle strength [1, 5, 8, 21–24].  Genetics may also 
regulate the muscle adaptation to training and it was found that improvement 
in one repetition maximum (1RM), static strength, and concentric flexion 
were influenced by genetic-environment interactions [20]. AGT encodes 
for angiotensinogen, an activity modulator of the renin- angiotensin system 
(RAS) [6], known to affect muscle growth and power. We recently demon-
strated that single nucleotide polymorphism (SNP) in the AGT genotype 
(Thr-Thr), was significantly more prevalent among weightlifters compared 
to sprinters, jumpers and controls [19]. The results indicated that despite 
common features of these sport subtypes (short and very intense), they vary 
in their strength and speed abilities, as well as in their genetic make-up. The 
aim of the present study was to assess whether the AGT SNP can be used 
also to distinguish elite from national levels weightlifters.
MATERIALS AND METHODS
Participants
Forty-seven weightlifters (38 males and 9 females, age 20–49) and 86 non-
athletes controls (55 males and 31 females, age 17–39) participated in the 
study. All athletes competed in national and/or international level meets on 
a regular basis. Thirty weightlifters were classified as elite athletes (partici-
pants and winners in international competitions, including European and 
World Championships, and Olympic Games). Controls were not engaged 
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in physical activity on a regular basis. The study was approved by the Insti-
tutional Review Board of the Hillel Yaffe Medical Center, Hadera, Israel, 
according to the Declaration of Helsinki. A written informed consent was 
obtained from each participant.
Genotyping
Genomic DNA was extracted from samples of peripheral venous blood 
according to the salting-out procedure. Genotypes were determined using 
the Taqman allelic discrimination assay. The Assay-by-Design service 
(www.appliedbio-systems.com) was used to set up a Taqman allelic discrim-
ination assays. Primer sequences were: forward: CCGTTTGTGCAGGGC-
CTGGCTCTCT, reverse: CAGGGTGCTGTCCACACTGGACCCC. Probe 
sequences were for M235T, forward: VIC- CTATCGGGAGGGTTG, reverse: 
FAM- CTATCGGAAGGGTTG.
The PCR reaction mixture included 5 ng genomic DNA, 0.125 μl TaqMan 
assay (40*, ABI), 2.5 μl Master mix (ABI) and 2.375 μl water. PCR was per-
formed in 384 well PCR plates in an ABI 9700 PCR system (Applied Bio-
systems Inc., Foster City, CA, USA) and consisted of initial denaturation for 
10  min at 95  °C, and 40 cycles with denaturation of 15 s at 92  °C and anneal-
ing and extension for 60 s at 60  °C. Results were analyzed by the ABI Taqman 
7900HT using the sequence detection system 2.22 software (Applied Bio-
systems Inc).
Data Analysis
The SPSS statistical package, version 20.0, was used to perform all statistical 
evaluations (SPSS, Chicago, IL, USA). A χ2-test was used to confirm that 
the observed genotype frequencies were within the Hardy-Weinberg equi-
librium and to compare alleles and genotype frequencies between athletes 
and controls, as well as between athletes from different competitive levels. 
If observed or expected values included a cell with a value of 5, we used 
Fisher’s exact test to compare alleles and genotype frequencies.
RESULTS
The complete allele and genotype frequencies data are presented in Table 1. 
The genotype subtype did not differ by age or sex. The AGT M235T geno-
type distribution was in agreement with the Hardy-Weinberg equilibrium 
in controls (p=0.54), national-level weightlifters (p=0.75), and top-level 
weightlifters (p=0.97).
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Table 1. AGT Met235Thr Genotypes and alleles frequencies, n (%)
Control
Weight lifters
National level Top level Total
n 86 17 30 47
Met-Met 32 (37.2) 4 (23.5) 5 (16.7) 9 (19.2)
Met-Thr 43 (50.0) 8 (47.1) 16 (53.3) 24 (51.0)
Thr-Thr 11 (12.8) 5 (29.4) 9 (30.0) 14 (29.8)
Thr allele carriers 54 (62.8) 13 (76.5) 25 (83.3) 38 (80.8)
Met allele 107 (62.2) 16 (47.1) 26 (43.3) 42 (44.7)
Thr allele 65 (37.8) 18 (52.9) 34 (56.7) 52 (55.3)
χ2(1)=3.90; p=0.048 for AGT Thr-Thr genotype frequency, Weight lifters vs. Controls
χ22(1)=5.35; p=0.021for AGT Met235Thr allele frequency, Weight lifters vs. Controls
Figure 1. AGT Met235Thr alleles and genotype frequencies among weightlifters.
*χ2(1)=3.90; p=0.048 for AGT Thr-Thr genotype frequency, Weight lifters vs. Controls
**χ2(1)=5.35; p=0.021 for AGT Met235Thr allele frequency, Weight lifters vs. Controls
AGT Met235Thr genotype and allele frequencies are presented in Figure 1. 
The AGT Met235Thr genotype frequencies were different among weightlift-
ers compared to controls. Overall, the Thr-Thr genotype was significantly 
higher among weightlifters (29.8%) compared to controls (12.8%) (p=0.048). 
Thr allele frequency was significantly higher among weightlifters (55.3%) 
compared to controls (37.8%) (p=0.021). However, The AGT Met235Thr 
genotype and allele frequencies were not significantly different among top-
level compared to national-level weightlifters.
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 DISCUSSION
Recent studies attempted to identify genetic variants associated with elite 
athletic performance. These studies relied primarily on the candidate 
gene approach and SNP relations with top world class performance using 
 frequently small sample size cohorts from different geographic areas and 
ethnicities. However, while several genes have been found to potentially 
assist in sport selection and explain athletic success, and while genetic assess-
ment may eventually become part of future talent identification, genetic test-
ing predictive value is poor at the present time [17]. In the present study, we 
assessed the prevalence of the AGT M235T (rs699, 4072T>C) polymorphism 
among national level and elite weightlifters. Our main findings were a signi-
ficantly higher prevalence of AGT 235T polymorphism among weightlifters 
compared to controls. However, there was no dif ference in the prevalence of 
the polymorphism between national level and elite athletes suggesting that 
this polymorphism cannot determine or predict elite competitive weight-
lifting performance. 
Angiotensinogen (AGT) plays an important role in the renin-angiotensin 
system (RAS) by activation of angiotensin I and II (ANG I & II) produc-
tion [6]. The RAS controls cardiovascular and renal functions, inflammatory 
cytokine and free radical production [4] as well as cell growth and prolife-
ration [7]. M235T (rs699, 4072T>C) is a missense polymorphism that leads 
to T to C transition at position 4072 in exon 2 and results in a replacement 
of the amino acid methionine (M) by threonine (T) at residue 235 of the 
mature AGT. The M235T polymorphism effects plasma AGT concentra-
tion, with C allele (Thr) carriers having 10–30% higher AGT levels [14], 
and subsequently a higher ANG II level, a skeletal muscle growth factor 
[18]. Mechanisms that may explain the ANG II effect on muscle perfor-
mance include a direct skeletal muscle hypertrophic effect, and redistribu-
tion of intra-muscular blood flow from the slow type I to the fast and power-
ful type II fibers, thereby augmenting power and strength capability [15]. 
Consistent with that previous studies have reported a higher prevalence of 
the AGT CC genotype in power athletes [11, 25]. In addition, we recently 
demonstrated [19]a high prevalence of the AGT CC genotype (Thr-Thr) 
among weight lifters (25.9%) compared to extremely low prevalence among 
sprinters (4.2%). This suggests that different genetic makeups enable athletic 
excellence in speed-oriented (e.g., sprints and jumps), and strength-oriented 
events (e.g., weightlifting). Moreover, the results suggest that combining dif-
ferent disciplines in sports genetic research should not be done, or at least 
should be done with extreme caution [2].
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In conclusion, the main finding of the present study was that despite 
the higher prevalence among weightlifters, the AGT polymorphism cannot 
distinguish between top and national level athletes. Although it is  possible 
that other genetic polymorphisms may determine weightlifting success, 
this finding emphasizes the concept that while a favourable genetic predis-
position is essential in sports, other associated factors such as training expe-
rience, superior equipment and facilities, adequate nutrition, greater familial 
support, and motivational factors, are crucial for top-level sports develop-
ment as well.
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